Compare PRGO & LC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | LC |
|---|---|---|
| Founded | 1887 | 2006 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1991 | 2014 |
| Metric | PRGO | LC |
|---|---|---|
| Price | $14.20 | $15.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $20.33 | ★ $22.67 |
| AVG Volume (30 Days) | 2.3M | ★ 2.7M |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | ★ 7.89% | N/A |
| EPS Growth | N/A | ★ 157.78 |
| EPS | N/A | ★ 1.16 |
| Revenue | ★ $4,281,800,000.00 | $1,334,719,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.27 |
| P/E Ratio | ★ N/A | $13.82 |
| Revenue Growth | N/A | ★ 14.97 |
| 52 Week Low | $12.17 | $7.90 |
| 52 Week High | $30.93 | $21.67 |
| Indicator | PRGO | LC |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 30.04 |
| Support Level | $13.58 | $16.20 |
| Resistance Level | $14.82 | $17.72 |
| Average True Range (ATR) | 0.54 | 0.96 |
| MACD | -0.05 | -0.58 |
| Stochastic Oscillator | 34.26 | 7.54 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.